vs
LXP Industrial Trust(LXP)与MARAVAI LIFESCIENCES HOLDINGS, INC.(MRVI)财务数据对比。点击上方公司名可切换其他公司
LXP Industrial Trust的季度营收约是MARAVAI LIFESCIENCES HOLDINGS, INC.的1.7倍($86.7M vs $49.9M),LXP Industrial Trust净利率更高(33.2% vs -71.6%,领先104.7%),MARAVAI LIFESCIENCES HOLDINGS, INC.同比增速更快(-11.8% vs -14.0%),过去两年LXP Industrial Trust的营收复合增速更高(0.3% vs -11.9%)
LXP工业信托是一家公开上市的房地产投资信托,专注于持有、运营和投资美国核心市场的优质工业地产,主要涵盖配送中心、物流设施及轻型工业物业,服务电商、第三方物流、先进制造等领域租户,为投资者创造长期稳定收益。
Maravai生命科学控股是一家全球化生命科学企业,专注于开发供应关键试剂、诊断产品及技术解决方案,服务于生物制药研发、药物开发、临床诊断及细胞和基因疗法制造领域,客户覆盖全球相关科研、医疗和企业机构。
LXP vs MRVI — 直观对比
营收规模更大
LXP
是对方的1.7倍
$49.9M
营收增速更快
MRVI
高出2.2%
-14.0%
净利率更高
LXP
高出104.7%
-71.6%
两年增速更快
LXP
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $86.7M | $49.9M |
| 净利润 | $28.8M | $-35.7M |
| 毛利率 | 81.5% | 25.8% |
| 营业利润率 | 34.6% | -117.9% |
| 净利率 | 33.2% | -71.6% |
| 营收同比 | -14.0% | -11.8% |
| 净利润同比 | — | -37.7% |
| 每股收益(稀释后) | — | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LXP
MRVI
| Q4 25 | $86.7M | $49.9M | ||
| Q3 25 | $86.9M | $41.6M | ||
| Q2 25 | $87.7M | $47.4M | ||
| Q1 25 | $88.9M | $46.9M | ||
| Q4 24 | $100.9M | $56.6M | ||
| Q3 24 | $85.6M | $69.0M | ||
| Q2 24 | $85.8M | $69.4M | ||
| Q1 24 | $86.3M | $64.2M |
净利润
LXP
MRVI
| Q4 25 | $28.8M | $-35.7M | ||
| Q3 25 | $36.3M | $-25.6M | ||
| Q2 25 | $29.1M | $-39.6M | ||
| Q1 25 | $19.0M | $-29.9M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | $6.3M | $-97.1M | ||
| Q2 24 | $5.4M | $-9.8M | ||
| Q1 24 | $-269.0K | $-12.1M |
毛利率
LXP
MRVI
| Q4 25 | 81.5% | 25.8% | ||
| Q3 25 | 82.3% | 13.6% | ||
| Q2 25 | 81.9% | 16.4% | ||
| Q1 25 | 80.7% | 16.5% | ||
| Q4 24 | 85.3% | 34.3% | ||
| Q3 24 | 82.5% | 46.7% | ||
| Q2 24 | 82.0% | 44.4% | ||
| Q1 24 | 82.4% | 40.3% |
营业利润率
LXP
MRVI
| Q4 25 | 34.6% | -117.9% | ||
| Q3 25 | 50.4% | -98.6% | ||
| Q2 25 | 33.7% | -139.8% | ||
| Q1 25 | 21.8% | -104.9% | ||
| Q4 24 | — | -66.7% | ||
| Q3 24 | 7.9% | -239.9% | ||
| Q2 24 | 6.9% | -19.4% | ||
| Q1 24 | 1.0% | -29.4% |
净利率
LXP
MRVI
| Q4 25 | 33.2% | -71.6% | ||
| Q3 25 | 41.7% | -61.4% | ||
| Q2 25 | 33.2% | -83.5% | ||
| Q1 25 | 21.4% | -63.9% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | 7.4% | -140.6% | ||
| Q2 24 | 6.3% | -14.1% | ||
| Q1 24 | -0.3% | -18.8% |
每股收益(稀释后)
LXP
MRVI
| Q4 25 | — | $-0.24 | ||
| Q3 25 | $0.12 | $-0.18 | ||
| Q2 25 | $0.09 | $-0.27 | ||
| Q1 25 | $0.06 | $-0.21 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | $0.02 | $-0.68 | ||
| Q2 24 | $0.01 | $-0.07 | ||
| Q1 24 | $-0.01 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $216.9M |
| 总债务越低越好 | $1.4B | $291.8M |
| 股东权益账面价值 | $2.0B | $212.4M |
| 总资产 | $3.5B | $770.6M |
| 负债/权益比越低杠杆越低 | 0.66× | 1.37× |
8季度趋势,按日历期对齐
现金及短期投资
LXP
MRVI
| Q4 25 | $170.4M | $216.9M | ||
| Q3 25 | $229.7M | $243.6M | ||
| Q2 25 | $71.0M | $269.9M | ||
| Q1 25 | $70.9M | $285.1M | ||
| Q4 24 | $101.8M | $322.4M | ||
| Q3 24 | $55.0M | $578.2M | ||
| Q2 24 | $48.7M | $573.2M | ||
| Q1 24 | $293.8M | $561.7M |
总债务
LXP
MRVI
| Q4 25 | $1.4B | $291.8M | ||
| Q3 25 | $1.5B | $292.8M | ||
| Q2 25 | $1.5B | $293.9M | ||
| Q1 25 | $1.5B | $294.9M | ||
| Q4 24 | $1.6B | $295.9M | ||
| Q3 24 | — | $521.7M | ||
| Q2 24 | — | $522.5M | ||
| Q1 24 | — | $523.3M |
股东权益
LXP
MRVI
| Q4 25 | $2.0B | $212.4M | ||
| Q3 25 | $2.1B | $245.4M | ||
| Q2 25 | $2.1B | $265.9M | ||
| Q1 25 | $2.1B | $300.6M | ||
| Q4 24 | $2.1B | $325.3M | ||
| Q3 24 | $2.1B | $344.9M | ||
| Q2 24 | $2.1B | $434.7M | ||
| Q1 24 | $2.2B | $410.7M |
总资产
LXP
MRVI
| Q4 25 | $3.5B | $770.6M | ||
| Q3 25 | $3.7B | $849.2M | ||
| Q2 25 | $3.7B | $897.0M | ||
| Q1 25 | $3.8B | $959.8M | ||
| Q4 24 | $3.8B | $1.0B | ||
| Q3 24 | $3.9B | $1.3B | ||
| Q2 24 | $3.9B | $1.4B | ||
| Q1 24 | $4.2B | $1.4B |
负债/权益比
LXP
MRVI
| Q4 25 | 0.66× | 1.37× | ||
| Q3 25 | 0.72× | 1.19× | ||
| Q2 25 | 0.72× | 1.11× | ||
| Q1 25 | 0.73× | 0.98× | ||
| Q4 24 | 0.75× | 0.91× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 1.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $188.7M | $-22.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-24.9M |
| 自由现金流率自由现金流/营收 | — | -49.9% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | 6.56× | — |
| 过去12个月自由现金流最近4个季度 | — | $-70.7M |
8季度趋势,按日历期对齐
经营现金流
LXP
MRVI
| Q4 25 | $188.7M | $-22.8M | ||
| Q3 25 | $63.5M | $-15.2M | ||
| Q2 25 | $44.3M | $-10.3M | ||
| Q1 25 | $39.0M | $-9.4M | ||
| Q4 24 | $211.2M | $-14.6M | ||
| Q3 24 | $64.6M | $13.1M | ||
| Q2 24 | $38.5M | $17.4M | ||
| Q1 24 | $38.9M | $-8.5M |
自由现金流
LXP
MRVI
| Q4 25 | — | $-24.9M | ||
| Q3 25 | — | $-18.1M | ||
| Q2 25 | — | $-13.1M | ||
| Q1 25 | — | $-14.6M | ||
| Q4 24 | — | $-20.5M | ||
| Q3 24 | — | $4.5M | ||
| Q2 24 | — | $7.9M | ||
| Q1 24 | — | $-14.1M |
自由现金流率
LXP
MRVI
| Q4 25 | — | -49.9% | ||
| Q3 25 | — | -43.4% | ||
| Q2 25 | — | -27.7% | ||
| Q1 25 | — | -31.2% | ||
| Q4 24 | — | -36.2% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | 11.4% | ||
| Q1 24 | — | -22.0% |
资本支出强度
LXP
MRVI
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | — | 12.4% | ||
| Q2 24 | — | 13.8% | ||
| Q1 24 | — | 8.8% |
现金转化率
LXP
MRVI
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LXP
暂无分部数据
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |